Table 2.
Atrial Fibrillation Effect on Quality of Life scores, baseline and 30-day follow-up, by treatment arm.
| Scores and subscores | Control, mean (SD) | Intervention, mean (SD) | Adjusted mean difference | ||||
|
|
Baseline | Follow-up | Baseline | Follow-up | Adjusted mean difference (95% CI)a | P valueb | |
| AFEQTc symptom | 83.7 (19.7) | 82.8 (21.2) | 85.9 (14.5) | 87.6 (15.2) | 3.1 (−1.3 to 9.6) | .26 | |
| AFEQT daily activity | 69.6 (23.8) | 69.5 (22.3) | 77.6 (19.9) | 82.6 (18.6) | 7.1 (1.8 to 12.4) | .009 | |
| AFEQT treatment | 79.4 (20.1) | 80.4 (21.2) | 83.8 (15.7) | 87.1 (14.8) | 2.9 (−1.9 to 7.8) | .24 | |
| AFEQT satisfaction | 79.3 (22.9) | 79.3 (19.3) | 78.5 (23.1) | 83.3 (20.9) | 4.3 (−2.6 to 11.3) | .22 | |
| AFEQT total | 76.0 (17.6) | 76.1 (16.7) | 81.5 (14.2) | 85.2 (14.1) | 4.5 (0.6 to 8.3) | .03 | |
aEstimate of the adjusted mean difference (95% CI) between follow-up AFEQT score in intervention group versus control group from analysis of covariance model with follow-up AFEQT score as outcome variable, adjusting for baseline score as covariate.
bP value from analysis of covariance model comparing follow-up AFEQT score between intervention group versus control group with adjustment for baseline score.
cAFEQT: Atrial Fibrillation Effect on Quality of Life.